Ocugen Inc at Citi BioPharma Conference (Virtual) Transcript
Good afternoon, everyone, and welcome to Citi's Biopharma Virtual Conference. My name is Max Riso, I'm a director within Citi's healthcare investment banking team. It is my pleasure today to introduce you to Ocugen. Ocugen's mission is to develop gene therapies to cure blindness and to develop a vaccine to save lives from COVID-19. Joining us today from the Company is CEO Shankar Musunuri who will be walking us through the Company's presentation. On a brief housekeeping note, we kindly ask to reserve all questions for Q&A at the end of the presentation. With that, Shankar, I will turn it over to you. Thank you.
Thank you, Max. Good afternoon, everyone. Thank you for tuning in to Ocugen's presentation today. Forward-looking statement. We're a biotech company strong diversified portfolio in many areas starting with vaccines and breakthrough gene therapies and novel biologicals. Our first program vaccine COVID-19 vaccine it's going through approval process in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |